Mar 25, 2026 04:22PM
Feb 19, 2026 09:00AM
Jun 26, 2025 04:01PM
Apr 28, 2025 04:00PM
Apr 15, 2025 04:16PM
Feb 13, 2025 11:34AM
Dec 23, 2024 08:45AM Devonian Health Group Reports First Quarter 2025 Financial Results and Grants Stock Options
Nov 29, 2024 08:45AM
Jul 8, 2024 08:45AM
Jun 25, 2024 04:15PM
Jun 25, 2024 04:05PM
Mar 28, 2024 08:45AM
Mar 14, 2024 08:45AM
Feb 27, 2024 08:45AM Devonian Announces that its Subsidiary, Altius, Launches Authorized Generic of Dexlansoprazole (Dexilant®) in Canada
Jan 19, 2024 04:42PM
Dec 4, 2023 08:45AM
Nov 8, 2023 08:45AM
Sep 1, 2023 04:00PM
Jun 20, 2023 08:45AM
Jun 6, 2023 06:30PM
May 19, 2023 04:00PM Devonian Announces Private Placement of up to $5 Million
May 16, 2023 08:45AM
May 12, 2023 08:45AM
May 11, 2023 08:55AM
Mar 30, 2023 04:00PM
Mar 24, 2023 04:00PM
Feb 22, 2023 08:45AM
Jan 26, 2023 08:45AM Devonian Health Group Announces its Participation at BIO CEO & Investor Conference
Jan 6, 2023 04:00PM
Oct 24, 2022 08:45AM
Oct 12, 2022 08:45AM
Oct 6, 2022 08:45AM
Sep 7, 2022 04:00PM
Aug 29, 2022 04:00PM
May 26, 2022 08:45AM Devonian Health Group Announces the Journal of Drugs in Dermatology Acceptance for Publication of Thykamine™ Positive Phase 2 Clinical Trial Results in Atopic Dermatitis
Mar 17, 2022 04:30PM
Mar 10, 2022 08:45AM

322,905 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All